Bicara Therapeutics Inc (NAS:BCAX)
$ 29.34 +2.47 (+9.19%) Market Cap: 1.93 Bil Enterprise Value: 1.39 Bil PE Ratio: 0 PB Ratio: 3.74 GF Score: 12/100

Bicara Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2026 / 01:00PM GMT
Release Date Price: $20.56 (+2.29%)
Claire Mazumdar Bicara Therapeutics Inc;Chief Executive Officer
Director

Good morning, everyone. Welcome to the 2026 Bicara Therapeutics Annual Meeting of Stockholders. Please note that today's meeting is being recorded. My name is Claire Mazumdar, Chief Executive Officer of the company, and I will serve as the chairperson for today's meeting. The annual meeting of stockholders is now called to order. I've asked Gabriela Morales Rivera of Goodwin Procter, our outside legal counsel, to record the minutes.

Before we proceed, I would like to let you know that members of our Board and our management team have joined us virtually. Also with us today are representatives from KPMG, the company's independent registered public accounting firm.

The rules of conduct for this meeting are available in the file section in the lower right-hand corner of the screen. Now let's proceed with the formal business of the meeting. This meeting is being held in accordance with the company's bylaws and Delaware law.

The matters to be considered at this meeting are described in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot